The Good Pharma Scorecard, as its acronym suggests, is the industry GPS for clinical trial transparency. Bioethics International, founded in 2005 by Jennifer Miller, Ph.D., is the organization behind the Good Pharma Scorecard. The ranking rates biopharmaceutical companies and new drugs on their clinical trial transparency and data-sharing performance, taking into account ethics and legal standards.
According to the Good Pharma Scorecard website, clinical trial transparency and data sharing are important for several reasons, including:
- Transparency is key to protecting and respecting research participants and users of medicines and vaccines
- Transparency is key to maximizing the value of generated trial data and people’s participation in trials
- Opacity can drive up costs of research and care
What do the Top 5 sponsors in transparency and data sharing all have in common? They rely on TrialScope Disclose to manage clinical trial disclosure.
In addition to benefiting patients, the Good Pharma Scorecard also is a positive for sponsors. We spoke with disclosure experts at two of the Top 5 sponsors on the list, who explain why the ranking is so important to their organizations and to the industry as a whole.